| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 4-amino-N-[4-(trifluoromethyl)phenyl]benzamide |
4-amino-N-[4-(trifluoromethyl)phenyl]benzamide |
1011244-72-6 |
詳細
|
| PF 3845 |
PF 3845 |
1196109-52-0 |
詳細
|
| AST 487 |
AST 487 |
630124-46-8 |
詳細
|
| SAR-407899 |
6-(哌啶-4-氧基)異喹啉-1(2H)-酮鹽酸鹽 |
923262-96-8 |
詳細
|
| GNE7915 |
GNE7915 |
1351761-44-8 |
詳細
|
| Volitinib |
沃利替尼 |
1313725-88-0 |
詳細
|
| JNJ 42041935 |
JNJ 42041935 |
1193383-09-3 |
詳細
|
| AD80 |
AD80 |
1384071-99-1 |
詳細
|
| ROSCOVITINE |
細胞周期蛋白B激酶抑制劑 |
186692-46-6 |
詳細
|
| (Rac)-Benpyrine |
(Rac)-Benpyrine |
1333714-43-4 |
詳細
|
| CRA-02478 |
PCI-24781 |
783355-60-2 |
詳細
|
| Ponatinib |
帕納替尼 |
943319-70-8 |
詳細
|
| AZD-1390 |
CS-2816 |
2089288-03-7 |
詳細
|
| (6S,9S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl- 4,7-dioxo-8-(quinolin-8-ylmethyl)hexahydro-2H- pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide |
1422253-37-9 |
1422253-37-9 |
詳細
|
| 1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine |
AC1903 |
831234-13-0 |
詳細
|
| (S)-2-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1H-benzo[d]imidazole-5-carboxamide |
(S)-2-(6-溴苯并[D][1,3]二氧雜環(huán)戊烯-5-基)-N-(4-氰基苯基)-1-(1-環(huán)己基乙基)-1H-苯并[D]咪唑-5-甲酰胺 |
2100284-59-9 |
詳細
|
| RAD51-IN-17 |
RAD51-IN-17 |
2101739-18-6 |
詳細
|
| GRP-60367 |
(4-((2-(2,5-二甲基苯氧基)乙基)氨基)哌啶-1-基)(吡啶-4-基)甲酮 |
1309241-34-6 |
詳細
|
| 4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
2160546-07-4 |
詳細
|
| GR 125743 |
化合物GR 125743 |
148547-33-5 |
詳細
|
| L-765314 |
L-765314 |
189349-50-6 |
詳細
|
| NG25 |
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺 |
1315355-93-1 |
詳細
|
| BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)- |
氟馬替尼 |
895519-90-1 |
詳細
|
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-環(huán)己醇 |
1429881-91-3 |
詳細
|
| RGFP966 |
(2E)-N-(2-氨基-4-氟苯基)-3-[1-(3-苯基-2-丙烯-1-基)-1H-吡唑-4-基]-2-丙烯酰胺 |
1396841-57-8 |
詳細
|
| PEXMETINIB |
PEXMETINIB |
945614-12-0 |
詳細
|
| 2-(1-Phenyl-cyclopropylamino)-pyrimidine-5-carboxylic acid hydroxyamide |
N-羥基-2-[(1-苯基環(huán)丙基)氨基]-5-嘧啶甲酰胺 |
1375465-91-0 |
詳細
|
| H3B-6527 |
H3B-6527 |
1702259-66-2 |
詳細
|
| CK1-IN-1 |
CK1-IN-1 |
1784751-20-7 |
詳細
|
| LMPTP INHIBITOR 1 dihydrochloride |
LMPTP INHIBITOR 1 dihydrochloride |
2310135-46-5 |
詳細
|
| Cotosudil |
化合物 COTOSUDIL |
1258833-31-6 |
詳細
|
| YB-0158 |
YB-0158 |
1144043-83-3 |
詳細
|
| Tapinarof |
苯烯莫德 |
79338-84-4 |
詳細
|
| Bisindolylmaleimide VIII acetate |
3-[1-(3-氨基丙基)-1H-吲哚-3-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮單乙酸鹽 |
138516-31-1 |
詳細
|
| 2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]aceticacidmethylester |
CS-1226 |
431979-47-4 |
詳細
|
| (±)-1-[(3aR*,4S*,9bS*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone |
881639-98-1 |
881639-98-1 |
詳細
|
| AMG 487 |
AMG 487 |
473719-41-4 |
詳細
|
| SGC 0946 |
SGC0946 |
1561178-17-3 |
詳細
|
| ALK/IGF1R inhibitor |
AZD3463 |
1356962-20-3 |
詳細
|
| SR2516 |
PND1186 |
1061353-68-1 |
詳細
|
| AZD2858 |
AZD2858 |
486424-20-8 |
詳細
|
| RG120 |
艾伏尼布 |
1448347-49-6 |
詳細
|
| TM 5275 |
CS-2524 |
1103926-82-4 |
詳細
|
| CWP232228 |
化合物CWP232228 |
1144044-02-9 |
詳細
|
| JNJ-18038683 |
化合物JNJ-18038683 |
851376-05-1 |
詳細
|
| ROCK inhibitor-2 |
ROCK inhibitor-2 |
1127308-52-4 |
詳細
|
| PF 573228 |
6-[(4-((3-(甲磺?；?芐基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氫-1H-喹啉-2-酮 |
869288-64-2 |
詳細
|
| GSK-1070916 |
GSK1070916 |
942918-07-2 |
詳細
|
| γ-Secretase Inhibitor XXI |
N-[(1S)-2-[[(3S)-2,3-二氫-1-甲基-2-氧代-5-苯基-1H-1,4-苯并二氮雜卓-3-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺 |
209986-17-4 |
詳細
|
| RO-0335 |
RO0335 |
867365-76-2 |
詳細
|
| Practolol |
普拉洛爾 |
6673-35-4 |
詳細
|
| 2-[(Cyclopropylsulfonyl)amino]-N-(2-ethoxyphenyl)benzamide |
2-[(Cyclopropylsulfonyl)amino]-N-(2-ethoxyphenyl)benzamide |
1646499-97-9 |
詳細
|
| CITCO |
CITCO |
338404-52-7 |
詳細
|
| Pizuglanstat |
化合物PIZUGLANSTAT |
1244967-98-3 |
詳細
|
| Finasteride Carboxaldehyde |
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-二甲基-2-氧代乙基)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-十四氫-4a,6a-二甲基-2-氧代-1H-茚并[5,4-f]喹啉-7-羧酰胺 |
154387-61-8 |
詳細
|
| NVP-BGJ398 |
FGFR抑制劑(NVP-BGJ398) |
872511-34-7 |
詳細
|
| AUZ 454 |
K03861 |
853299-07-7 |
詳細
|
| LY-2584702 (tosylate salt) |
LY2584702 TOSYLATE |
1082949-68-5 |
詳細
|
| Enasidenib |
恩西地平 |
1446502-11-9 |
詳細
|
| GSK2982772 |
GSK2982772 |
1622848-92-3 |
詳細
|
| SHP-099 |
SHP-099游離 |
1801747-42-1 |
詳細
|
| CYC-065 |
CYC-065 |
1070790-89-4 |
詳細
|
| Aumitin |
AUMITIN |
946293-78-3 |
詳細
|
| ML 792 |
ML792 |
1644342-14-2 |
詳細
|
| 1(2H)-Phthalazinone, 4-[[3-[[3-[(cyclopropylamino)methyl]-1-azetidinyl]carbonyl]-4-fluorophenyl]methyl]- |
Venadaparib |
1681017-83-3 |
詳細
|
| MLN-8237 |
阿立塞替 |
1028486-01-2 |
詳細
|
| GSK2334470 |
GSK2334470 |
1227911-45-6 |
詳細
|
| ALK inhibitor 2 |
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺 |
761438-38-4 |
詳細
|
| PRN-1371 |
PRN1371 |
1802929-43-6 |
詳細
|
| Elsulfavirine |
Elsulfavirine |
868046-19-9 |
詳細
|
| Vodobatinib |
K0706 |
1388803-90-4 |
詳細
|
| 4-Pyrimidinamine, N-[[4-(1-methyl-1H-pyrazol-4-yl)phenyl]methyl]-6-[7-[3-(1-pyrrolidinyl)propoxy]imidazo[1,2-a]pyridin-3-yl]- |
化合物M4205 |
2590556-80-0 |
詳細
|
| Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester |
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester |
2448173-47-3 |
詳細
|
| GDC-0623 |
GDC-0623 |
1168091-68-6 |
詳細
|
| 7-chloroiMidazo[1,2-b]pyridazine |
7-氯咪唑[1,2-B]噠嗪 |
1383481-11-5 |
詳細
|
| X-376 |
恩沙替尼 |
1365267-27-1 |
詳細
|
| PKR-IN-1 |
PKR-IN-1 |
1260075-17-9 |
詳細
|
| DTZ |
DTZ |
344940-63-2 |
詳細
|
| ORY-2001 |
VAFIDEMSTAT |
1357362-02-7 |
詳細
|
| PD173955 |
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮 |
260415-63-2 |
詳細
|
| AZD8055 |
AZD8055 |
1009298-09-2 |
詳細
|
| 5-AMINO-2-(4-TERT-BUTYLPHENOXY)PYRIDINE |
6-[4-(叔丁基)苯氧基]吡啶-3-胺 |
218457-67-1 |
詳細
|
| SGI-1776 |
SGI-1776 |
1025065-69-3 |
詳細
|
| SLx-2119 |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-異丙基乙酰胺 |
911417-87-3 |
詳細
|
| ACY1215 |
ACY1215 |
1316214-52-4 |
詳細
|
| Cerdulatinib |
賽度替尼 |
1198300-79-6 |
詳細
|
| GS-9876 (lanraplenib) |
GS-9876 |
1800046-95-0 |
詳細
|
| PS210 |
PS 210 |
1221962-86-2 |
詳細
|
| Emedastine |
依美司丁 |
87233-61-2 |
詳細
|
| CI 934 |
CI 934 |
91188-00-0 |
詳細
|
| PVM/MA |
PVM/MA共聚物 |
1644545-52-7 |
詳細
|
| PD 166285 |
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮鹽酸鹽 |
212391-63-4 |
詳細
|
| RESATORVID |
瑞沙托維 |
243984-11-4 |
詳細
|
| WYE-354 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-嗎啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 |
1062169-56-5 |
詳細
|
| PP242 |
PP242 |
1092351-67-1 |
詳細
|
| AZD0364 |
CS-2696 |
2097416-76-5 |
詳細
|
| MS-402 |
MS-402 |
1672684-68-2 |
詳細
|
| Elexacaftor |
ELEXACAFTOR |
2216712-66-0 |
詳細
|
| RO-31-8220 |
RO-31-8220 |
138489-18-6 |
詳細
|
| A-83-01 |
3-(6-甲基-2-吡啶基)-N-苯基-4-(4-喹啉基)-1H-吡唑-1-硫代甲酰胺 |
909910-43-6 |
詳細
|